Pierluigi F. Salvo
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Dengue-specific T-cell memory following natural infection: a comparative analysis between people living with HIV and HIV-negative individuals.
Journal: Microbiology spectrum
Published: May 07, 2026
Risk of Virological Failure After Switch to a Tenofovir-Sparing Dual Therapy in Virologically Suppressed People With HIV and Past HBV Infection.
Journal: Journal of medical virology
Published: February 20, 2026
Clinical presentation and effectiveness of antiretroviral therapy in newly diagnosed people living with HIV before, during and after the COVID-19 pandemic.
Journal: BMJ public health
Published: December 17, 2025
Effectiveness of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) as switch strategy in virologically-suppressed patients: real world data from a monocentric cohort.
Journal: Antiviral therapy
Published: December 19, 2024
Real World Data from an Italian Outpatient Clinical Setting and from Home Care Assistance of Treatment-Experienced PWH Switching to CAB + RPV Regimen: A Prospective Observational Study.
Journal: AIDS and behavior
Published: December 18, 2024
Association among therapeutic adherence, health literacy, and engagement in care: How to increase health-conscious management of HIV disease.
Journal: International journal of STD & AIDS
Published: November 05, 2024
Cardiovascular Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in Virologically Suppressed PLWHIV: A Comparative Analysis of CVD Scores.
Journal: AIDS research and human retroviruses
Published: October 29, 2024
'With age comes wisdom': effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV.
Journal: AIDS (London, England)
Published: October 02, 2024
Last Updated: 09/26/2026